543 results
Interactive Case Corner 1 - Thrombosed AVG, bifurcation lesions & diffuse CAD
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover a selection of challenging clinical cases, such as myocardial revascularisation in diffuse CAD, PCI of bifurcation lesion with DK crush technique, angioplasty of totally thrombosed arteriovenous graft, and more!
Interactive Case Corner 4 - Wandering stent
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover the case of a high-risk patient accepted for LM and multivessel PCI, and learn more about the transulnar approach strategy and benefits.
Complex and challenging cases I
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn how to manage complex complications, with a selection of challenging clinical cases such as: high-risk left main artery, stent ablation and rota-stenting, LT main lesion, and more!
PCI optimisation: OCT and physiology in a complex multivessel disease case
18 Dec 2019 – From GulfPCR-GIM 2019
The patient is a 57-year-old male with high-risk factors and previous history of revascularisation. He presents with ischemic chest pain with NSTE-ACS. The baseline angiography shows multivessel disease and calcified LAD/D1 bifurcation (1,1,0).
The key objectives of this case are:
- Utility of FFR in physiological assessment of a...
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis
05 Nov 2019
A comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)
Reviewer
Reviewer
Undilatable calcific lesion even after rotational atherectomy
19 Dec 2019
View this very uncommon case in which balloons do not expand even after a rather aggressive rotational atherectomy: a 43-year-old male with hypertension, smoking and dyslipidemia presents with total occlusion of proximal left anterior descending artery with fresh thrombus...
Author
Author
Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?
18 Oct 2019
Over the past year, an abundance of clinical evidence has emerged addressing the conceptually appealing and theoretically justified concept of dropping aspirin, rather than the P2Y12 antagonist, as part of antiplatelet regimens after percutaneous coronary intervention (PCI).
Authors :
The future of medical device regulation in the European Union
New EU regulations on medical devices will come into force in 2020. Giulio Stefanini, Robert Byrne and Paul Piscoi discuss how new regulation is needed “to reflect the changes in the field over the last decades” and outline what this will mean for the safety of...
Ticagrelor with or without aspirin in high-risk patients after PCI
07 Oct 2019
The TWILIGHT trial was designed to test the hypothesis that in patients undergoing PCI who are at high risk for ischemic or hemorrhagic complications and who have completed a 3-month course of DAPT with ticagrelor plus aspirin, continued treatment with ticagrelor monotherapy would be superior to ticagrelor...
Reviewer
Editor's picks: impactful articles in interventional cardiology
01 Oct 2019
Struggling to keep up with the mass of scientific information in interventional cardiology? On this page you will find a selection of recent articles published in major journals in the field - use it to guide your reading!
